← Leaderboards
David H Vlahov
New York Academy Of Medicine
$30,228,718
Attributed
$31,338,865
Total exposure
17
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.1M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$31,338,865 · 17
By mechanism
R01$18,790,245 · 10
R37$7,609,410 · 1
R24$2,871,657 · 1
T32$1,442,982 · 1
R25$518,208 · 1
R13$106,363 · 3
Top collaborators
- Carmen J Portillo4 shared
- Xiaomei Sophia Cong2 shared
- Laron E Nelson2 shared
- Daniel F Sarpong2 shared
- Carol Dawson-Rose1 shared
Most similar at New York Academy Of Medicine
Same institution · by research overlap
- Crystal M Fuller$12,998,257
- Sandro Galea$13,292,734
- Danielle C Ompad$7,149,819
Others in their field
Top investigators on “Human Subject”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- George R Seage · Abt Associates, Inc.$172,422,660
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$160,455,836
- Jeffrey P Krischer · University Of South Florida$155,493,283
- Charles A Coltman · Southwest Oncology Group$154,811,913
Research focus
Human SubjectInterviewClinical ResearchIntravenous Drug AbuseHiv InfectionsBehavioral /Social Science Research TagDisease /Disorder Proneness /RiskHigh Risk Behavior /LifestyleCommunitiesPersonsCitiesHepatitis BAids Education /PreventionOutreachNeighborhoodsNew York CityDisadvantagedProgramsAreaSocialStatistics /BiometryStructureHepatitis C VirusEpidemiology
Grant awards (65)
Comprehensive Advancement in Research Education and Training for Social Determinants of Health (CARES)$253,532
R25 · FY2025 · NR
Comprehensive Advancement in Research Education and Training for Social Determinants of Health (CARES)$264,676
R25 · FY2024 · NR
HIV/AIDS Nursing Care and Prevention$296,876
T32 · FY2016 · NR
HIV/AIDS Nursing Care and Prevention$257,189
T32 · FY2015 · NR
HIV/AIDS Nursing Care and Prevention$295,175
T32 · FY2014 · NR
HIV/AIDS Nursing Care and Prevention$295,207
T32 · FY2013 · NR
Harlem Community Academic Partnership: Influenza Immunizations$575,514
R24 · FY2012 · MD · contact PI
HIV/AIDS Nursing Care and Prevention$298,535
T32 · FY2012 · NR
Harlem Community Academic Partnership: Influenza Immunizations$485,769
R24 · FY2011 · MD · contact PI
Harlem Community Academic Partnership: Influenza Immunizations$86,745
R24 · FY2011 · MD · contact PI
Harlem Community Academic Partnership: Influenza Immunizations$571,153
R24 · FY2010 · MD · contact PI
9th International Conference on Urban Health$71,174
R13 · FY2010 · MD · contact PI
Heroin Cessation and Hiv Risk: A Case-Control Study$51,215
R01 · FY2010 · DA · contact PI
Heroin Cessation and Hiv Risk: A Case-Control Study$639,711
R01 · FY2009 · DA · contact PI
The HIV Risk Behavior and the Urban Environment$586,706
R01 · FY2009 · DA · contact PI
Harlem Community Academic Partnership: Influenza Immunizations$576,637
R24 · FY2009 · MD · contact PI
Heroin Cessation and Hiv Risk: A Case-Control Study$639,543
R01 · FY2008 · DA · contact PI
The HIV Risk Behavior and the Urban Environment$589,669
R01 · FY2008 · DA · contact PI
Harlem Community Academic Partnership: Influenza Immunizations$575,839
R24 · FY2008 · MD · contact PI
The HIV Risk Behavior and the Urban Environment$99,777
R01 · FY2008 · DA · contact PI
7th International Conference on Urban Health$7,600
R13 · FY2008 · ES · contact PI
The HIV Risk Behavior and the Urban Environment$663,982
R01 · FY2007 · DA · contact PI
Heroin Cessation and Hiv Risk: A Case-Control Study$623,957
R01 · FY2007 · DA · contact PI
The HIV Risk Behavior and the Urban Environment$721,507
R01 · FY2006 · DA · contact PI
RAPID VACCINATION OF HARD TO REACH POPULATI0NS$709,936
R01 · FY2006 · DA · contact PI
Natural History of HIV Infection in Injection Drug Users$1,341,227
R37 · FY2005 · DA
RAPID VACCINATION OF HARD TO REACH POPULATI0NS$910,460
R01 · FY2005 · DA
The HIV Risk Behavior and the Urban Environment$489,866
R01 · FY2005 · DA
Mental health in NYC after WTC disaster$276,078
R01 · FY2005 · MH
The HIV Risk Behavior and the Urban Environment$36,001
R01 · FY2005 · DA
ICUH - 4th Annual Conference$27,589
R13 · FY2005 · DA
Natural History of HIV Infection in Injection Drug Users$1,306,165
R37 · FY2004 · DA
RAPID VACCINATION OF HARD TO REACH POPULATI0NS$707,046
R01 · FY2004 · DA
Expanded Syringe Access Program--NY Evaluation$703,685
R01 · FY2004 · DA
Mental health in NYC after WTC disaster$380,847
R01 · FY2004 · MH
Club Drug Use and HIV Risks among Minorities in NYC$326,715
R01 · FY2004 · DA
Mental health in NYC after WTC disaster$157,986
R01 · FY2004 · MH
RAPID VACCINATION OF HARD TO REACH POPULATI0NS$99,764
R01 · FY2004 · DA
RAPID VACCINATION OF HARD TO REACH POPULATI0NS$94,257
R01 · FY2004 · DA
Natural History of HIV Infection in Injection Drug Users$1,281,995
R37 · FY2003 · DA
Expanded Syringe Access Program--NY Evaluation$727,478
R01 · FY2003 · DA
RAPID VACCINATION OF HARD TO REACH POPULATI0NS$590,307
R01 · FY2003 · DA
Mental health in NYC after WTC disaster$587,141
R01 · FY2003 · MH
Natural History of HIV Infection in Injection Drug Users$14,925
R37 · FY2003 · DA
Natural History of HIV Infection in Injection Drug Users$1,275,216
R37 · FY2002 · DA
HEPATITIS C IN NEW IDUS: IMPLICATIONS FOR HIV PREVENTION$860,023
R01 · FY2002 · DA
Mental health in NYC after WTC disaster$556,721
R01 · FY2002 · MH
Expanded Syringe Access Program--NY Evaluation$516,187
R01 · FY2002 · DA
PREVENTION OF HIV AMONG NEW IDUS AND NON-IDUS IN HARLEM$415,530
R01 · FY2002 · DA
Expanded Syrings Access Program: NY Evaluation$320,489
R01 · FY2002 · DA
Prevalence/Correlates: Psychological Impact of WTC$287,229
R01 · FY2002 · MH
EVALUATING SUPERVISED HAART IN LATE STAGE HIV IN IDUS$277,886
R01 · FY2002 · DA
PREVENTION OF HIV AMONG NEW IDUS AND NON-IDUS IN HARLEM$77,004
R01 · FY2002 · DA
NATURAL HISTORY OF HIV INFECTION IN INJECTION DRUG USERS$1,211,172
R37 · FY2001 · DA
EVALUATING SUPERVISED HAART IN LATE STAGE HIV IN IDUS$649,374
R01 · FY2001 · DA
HEPATITIS C IN NEW IDUS: IMPLICATIONS FOR HIV PREVENTION$643,589
R01 · FY2001 · DA
PREVENTION OF HIV AMONG NEW IDUS AND NON-IDUS IN HARLEM$412,010
R01 · FY2001 · DA
Expanded Syringe Access Program--NY Evaluation$356,602
R01 · FY2001 · DA
Expanded Syringe Access Program--NY Evaluation$213,382
R01 · FY2001 · DA
HEPATITIS C IN NEW IDUS: IMPLICATIONS FOR HIV PREVENTION$107,900
R01 · FY2001 · DA
NATURAL HISTORY OF HIV INFECTION IN INJECTION DRUG USERS$1,160,398
R37 · FY2000 · DA
HEPATITIS C IN NEW IDUS: IMPLICATIONS FOR HIV PREVENTION$647,811
R01 · FY2000 · DA
EVALUATING SUPERVISED HAART IN LATE STAGE HIV IN IDUS$632,234
R01 · FY2000 · DA
PREVENTION OF HIV AMONG NEW IDUS AND NON-IDUS IN HARLEM$402,640
R01 · FY2000 · DA
NATURAL HISTORY OF HIV INFECTION IN INJECTION DRUG USERS$18,312
R37 · FY2000 · DA